FDA approves obesity drug Belviq
On Wednesday, the FDA approved the obesity drug Belviq, in conjunction with a reduced calorie diet and exercise, to treat chronic weight problems.
Vivus has presented additional data that demonstrates that its anti-obesity treatment candidate Qnexa significantly improves quality of life in obese patients, during the American Association of Diabetes Educators meeting in Las Vegas, Nevada.